VG-LC

N/A

Report date: 2026/01/23 17:55:19

Base Information

Drug NameVG-LC

Drug Alias Nametherapeutic vaccine based on Hsp60-derived carrier peptide plus polysaccharide antigen (Vacciguard/StressVax)VG-LC

ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Inactivated vaccine > Subunit vaccine

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsLung Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryIsrael

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesVacciguard Ltd

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesVacciguard Ltd

Active IndicationsN/A

Inactive IndicationsLung Neoplasms

ATC CodeN/A